Literature DB >> 20833652

Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin.

Alessandra Rossini1, Caterina Frati, Costanza Lagrasta, Gallia Graiani, Alessandro Scopece, Stefano Cavalli, Ezio Musso, Marco Baccarin, Marina Di Segni, Francesco Fagnoni, Antonia Germani, Eugenio Quaini, Manuel Mayr, Qingbo Xu, Andrea Barbuti, Dario DiFrancesco, Giulio Pompilio, Federico Quaini, Carlo Gaetano, Maurizio C Capogrossi.   

Abstract

AIMS: Bone marrow mesenchymal stromal cell (BMStC) transplantation into the infarcted heart improves left ventricular function and cardiac remodelling. However, it has been suggested that tissue-specific cells may be better for cardiac repair than cells from other sources. The objective of the present work has been the comparison of in vitro and in vivo properties of adult human cardiac stromal cells (CStC) to those of syngeneic BMStC. METHODS AND
RESULTS: Although CStC and BMStC exhibited a similar immunophenotype, their gene, microRNA, and protein expression profiles were remarkably different. Biologically, CStC, compared with BMStC, were less competent in acquiring the adipogenic and osteogenic phenotype but more efficiently expressed cardiovascular markers. When injected into the heart, in rat a model of chronic myocardial infarction, CStC persisted longer within the tissue, migrated into the scar, and differentiated into adult cardiomyocytes better than BMStC.
CONCLUSION: Our findings demonstrate that although CStC and BMStC share a common stromal phenotype, CStC present cardiovascular-associated features and may represent an important cell source for more efficient cardiac repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833652     DOI: 10.1093/cvr/cvq290

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  53 in total

Review 1.  Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage.

Authors:  Makeda K Stephenson; Ashley L Farris; Warren L Grayson
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

Review 2.  Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro.

Authors:  Patrick C Baer
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

Review 3.  Use of mesenchymal stem cells for therapy of cardiac disease.

Authors:  Vasileios Karantalis; Joshua M Hare
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

4.  Mesenchymal Stem Cells in Cardiology.

Authors:  Ian A White; Cristina Sanina; Wayne Balkan; Joshua M Hare
Journal:  Methods Mol Biol       Date:  2016

5.  Cardiac Nestin+ Mesenchymal Stromal Cells Enhance Healing of Ischemic Heart through Periostin-Mediated M2 Macrophage Polarization.

Authors:  Yan Liao; Guilan Li; Xiaoran Zhang; Weijun Huang; Dongmei Xie; Gang Dai; Shuanghua Zhu; Dihan Lu; Zhongyuan Zhang; Junyi Lin; Bingyuan Wu; Wanwen Lin; Yang Chen; Zhihong Chen; Chaoquan Peng; Maosheng Wang; Xinxin Chen; Mei Hua Jiang; Andy Peng Xiang
Journal:  Mol Ther       Date:  2020-01-15       Impact factor: 11.454

Review 6.  Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases.

Authors:  Kang Chen; Yuting Huang; Radhika Singh; Zack Z Wang
Journal:  J Cell Physiol       Date:  2020-01-29       Impact factor: 6.384

Review 7.  In vivo Cell Tracking Using Non-invasive Imaging of Iron Oxide-Based Particles with Particular Relevance for Stem Cell-Based Treatments of Neurological and Cardiac Disease.

Authors:  Markus Aswendt; Jean-Luc Boulland; Jasna Lojk; Stefan Stamenković; Joel C Glover; Pavle Andjus; Fabrizio Fiori; Mathias Hoehn; Dinko Mitrecic; Mojca Pavlin; Stefano Cavalli; Caterina Frati; Federico Quaini
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

8.  Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation.

Authors:  Sergey Ryzhov; Bong Hwan Sung; Qinkun Zhang; Alissa Weaver; Richard J Gumina; Italo Biaggioni; Igor Feoktistov
Journal:  Purinergic Signal       Date:  2014-03-01       Impact factor: 3.765

9.  The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism.

Authors:  Joseph B Moore; John Zhao; Matthew C L Keith; Alok R Amraotkar; Marcin Wysoczynski; Kyung U Hong; Roberto Bolli
Journal:  Stem Cells       Date:  2016-09-01       Impact factor: 6.277

10.  Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy.

Authors:  Joseph B Moore; Xian-Liang Tang; John Zhao; Annalara G Fischer; Wen-Jian Wu; Shizuka Uchida; Anna M Gumpert; Heather Stowers; Marcin Wysoczynski; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2018-11-16       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.